Global Gabapentin Market Size study & Forecast, by Type (Generic, Branded) by Dosage Form (Tablet, Capsule, Oral Solution), by Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Analysis, 2022-2029
Global Gabapentin Market is valued at approximately USD 2.02 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.35% over the forecast period 2022-2029.
Gabapentin is anti-convulsant, a form of drug that helps persons with epilepsy to control their seizures. The treatment of Restless legs syndrome (RLS) and specific types of nerve discomfort also includes the use of several gabapentin variants. Gabapentin works by affecting the electrical stimulation in the brain and inducing neurotransmitters, which communicate between nerve cells. The surging demand for generic formulations, coupled with the increasing use of the medicine as a pain reliever are the factors that are contributing to the market growth. Additionally, the rise in the number of elderly people, increasing government support activities, and growing investment in R&D by pharmaceutical companies are further stipulating the market demand across the globe.
The rise in incidences of neuropathic pain and epilepsy is further propelling the market's growth at a considerable rate. According to the World Health Organization (WHO), it is recorded that Epilepsy affects approximately 50 million people globally. Also, nearly 5 million people are diagnosed with epilepsy per year. Accordingly, several awareness campaigns including National Epilepsy Awareness Month in November are conducted to generate awareness to understand and control this medical condition. Thereby, the growing number of awareness campaigns and prevention programs, along with the rising prevalence of target diseases, is acting as a major catalyzing factor for the market demand. Furthermore, the rising number of government initiatives, as well as the development of emerging markets in emerging economies are presenting various lucrative prospects for market growth over the anticipated period. However, rising product (antibiotic) recalls, and increasing incidences of misuse of gabapentin are challenging factors for the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Gabapentin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of neurological disorders and chronic pain conditions, as well as rise in product approvals. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as an increase in point-of-care diagnostics, growing awareness regarding the benefits of gabapentin compared to opioids, and rising healthcare spending in the regional market.
Major market players included in this report are:
Zydus Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd.
Ascend Laboratories, LLC
Apotex Inc.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma.
Amneal Pharmaceuticals LLC.
Cipla USA, Inc.
BP Pharmaceuticals Laboratories Company
Recent Developments in the Market:
In December 2020, Glenmark Pharmaceuticals Limited declared that the company has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, the generic version of Cialis 1 Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg, of Eli Lilly and Company.
Global Gabapentin Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Dosage Form, Application, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Generic
Branded
By Dosage Form:
Tablet
Capsule
Oral Solution
By Application:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Gabapentin is anti-convulsant, a form of drug that helps persons with epilepsy to control their seizures. The treatment of Restless legs syndrome (RLS) and specific types of nerve discomfort also includes the use of several gabapentin variants. Gabapentin works by affecting the electrical stimulation in the brain and inducing neurotransmitters, which communicate between nerve cells. The surging demand for generic formulations, coupled with the increasing use of the medicine as a pain reliever are the factors that are contributing to the market growth. Additionally, the rise in the number of elderly people, increasing government support activities, and growing investment in R&D by pharmaceutical companies are further stipulating the market demand across the globe.
The rise in incidences of neuropathic pain and epilepsy is further propelling the market's growth at a considerable rate. According to the World Health Organization (WHO), it is recorded that Epilepsy affects approximately 50 million people globally. Also, nearly 5 million people are diagnosed with epilepsy per year. Accordingly, several awareness campaigns including National Epilepsy Awareness Month in November are conducted to generate awareness to understand and control this medical condition. Thereby, the growing number of awareness campaigns and prevention programs, along with the rising prevalence of target diseases, is acting as a major catalyzing factor for the market demand. Furthermore, the rising number of government initiatives, as well as the development of emerging markets in emerging economies are presenting various lucrative prospects for market growth over the anticipated period. However, rising product (antibiotic) recalls, and increasing incidences of misuse of gabapentin are challenging factors for the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Gabapentin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of neurological disorders and chronic pain conditions, as well as rise in product approvals. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as an increase in point-of-care diagnostics, growing awareness regarding the benefits of gabapentin compared to opioids, and rising healthcare spending in the regional market.
Major market players included in this report are:
Zydus Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd.
Ascend Laboratories, LLC
Apotex Inc.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma.
Amneal Pharmaceuticals LLC.
Cipla USA, Inc.
BP Pharmaceuticals Laboratories Company
Recent Developments in the Market:
In December 2020, Glenmark Pharmaceuticals Limited declared that the company has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, the generic version of Cialis 1 Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg, of Eli Lilly and Company.
Global Gabapentin Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Dosage Form, Application, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Generic
Branded
By Dosage Form:
Tablet
Capsule
Oral Solution
By Application:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gabapentin Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gabapentin Market, by Type, 2019-2029 (USD Billion)
1.2.3. Gabapentin Market, by Dosage Form, 2019-2029 (USD Billion)
1.2.4. Gabapentin Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gabapentin Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GABAPENTIN MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GABAPENTIN MARKET DYNAMICS
3.1. Gabapentin Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing investment in R&D by pharmaceutical companies
3.1.1.2. Rise in incidences of neuropathic pain and epilepsy
3.1.2. Market Challenges
3.1.2.1. Rising product (antibiotic) recalls
3.1.2.2. Increasing incidences of misuse of gabapentin
3.1.3. Market Opportunities
3.1.3.1. Rising number of government initiatives
3.1.3.2. Development of emerging markets in emerging economies
CHAPTER 4. GLOBAL GABAPENTIN MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL GABAPENTIN MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Gabapentin Market by Type, Performance - Potential Analysis
6.3. Global Gabapentin Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Gabapentin Market, Sub Segment Analysis
6.4.1. Generic
6.4.2. Branded
CHAPTER 7. GLOBAL GABAPENTIN MARKET, BY DOSAGE FORM
7.1. Market Snapshot
7.2. Global Gabapentin Market by Dosage Form, Performance - Potential Analysis
7.3. Global Gabapentin Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
7.4. Gabapentin Market, Sub Segment Analysis
7.4.1. Tablet
7.4.2. Capsule
7.4.3. Oral Solution
CHAPTER 8. GLOBAL GABAPENTIN MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Gabapentin Market by Application, Performance - Potential Analysis
8.3. Global Gabapentin Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gabapentin Market, Sub Segment Analysis
8.4.1. Epilepsy
8.4.2. Neuropathic Pain
8.4.3. Restless Legs Syndrome
8.4.4. Others
CHAPTER 9. GLOBAL GABAPENTIN MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Gabapentin Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Gabapentin Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Gabapentin Market, Sub Segment Analysis
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
CHAPTER 10. GLOBAL GABAPENTIN MARKET, REGIONAL ANALYSIS
10.1. Gabapentin Market, Regional Market Snapshot
10.2. North America Gabapentin Market
10.2.1. U.S. Gabapentin Market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gabapentin Market
10.3. Europe Gabapentin Market Snapshot
10.3.1. U.K. Gabapentin Market
10.3.2. Germany Gabapentin Market
10.3.3. France Gabapentin Market
10.3.4. Spain Gabapentin Market
10.3.5. Italy Gabapentin Market
10.3.6. Rest of Europe Gabapentin Market
10.4. Asia-Pacific Gabapentin Market Snapshot
10.4.1. China Gabapentin Market
10.4.2. India Gabapentin Market
10.4.3. Japan Gabapentin Market
10.4.4. Australia Gabapentin Market
10.4.5. South Korea Gabapentin Market
10.4.6. Rest of Asia Pacific Gabapentin Market
10.5. Latin America Gabapentin Market Snapshot
10.5.1. Brazil Gabapentin Market
10.5.2. Mexico Gabapentin Market
10.5.3. Rest of Latin America Gabapentin Market
10.6. Rest of The World Gabapentin Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Zydus Pharmaceuticals, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Glenmark Pharmaceuticals Limited
11.2.3. Sun Pharmaceutical Industries Ltd.
11.2.4. Ascend Laboratories, LLC
11.2.5. Apotex Inc.
11.2.6. Teva Pharmaceutical Industries Ltd.
11.2.7. Aurobindo Pharma.
11.2.8. Amneal Pharmaceuticals LLC.
11.2.9. Cipla USA, Inc.
11.2.10. BP Pharmaceuticals Laboratories Company
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gabapentin Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gabapentin Market, by Type, 2019-2029 (USD Billion)
1.2.3. Gabapentin Market, by Dosage Form, 2019-2029 (USD Billion)
1.2.4. Gabapentin Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gabapentin Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GABAPENTIN MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GABAPENTIN MARKET DYNAMICS
3.1. Gabapentin Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing investment in R&D by pharmaceutical companies
3.1.1.2. Rise in incidences of neuropathic pain and epilepsy
3.1.2. Market Challenges
3.1.2.1. Rising product (antibiotic) recalls
3.1.2.2. Increasing incidences of misuse of gabapentin
3.1.3. Market Opportunities
3.1.3.1. Rising number of government initiatives
3.1.3.2. Development of emerging markets in emerging economies
CHAPTER 4. GLOBAL GABAPENTIN MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL GABAPENTIN MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Gabapentin Market by Type, Performance - Potential Analysis
6.3. Global Gabapentin Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Gabapentin Market, Sub Segment Analysis
6.4.1. Generic
6.4.2. Branded
CHAPTER 7. GLOBAL GABAPENTIN MARKET, BY DOSAGE FORM
7.1. Market Snapshot
7.2. Global Gabapentin Market by Dosage Form, Performance - Potential Analysis
7.3. Global Gabapentin Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
7.4. Gabapentin Market, Sub Segment Analysis
7.4.1. Tablet
7.4.2. Capsule
7.4.3. Oral Solution
CHAPTER 8. GLOBAL GABAPENTIN MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Gabapentin Market by Application, Performance - Potential Analysis
8.3. Global Gabapentin Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gabapentin Market, Sub Segment Analysis
8.4.1. Epilepsy
8.4.2. Neuropathic Pain
8.4.3. Restless Legs Syndrome
8.4.4. Others
CHAPTER 9. GLOBAL GABAPENTIN MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Gabapentin Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Gabapentin Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Gabapentin Market, Sub Segment Analysis
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
CHAPTER 10. GLOBAL GABAPENTIN MARKET, REGIONAL ANALYSIS
10.1. Gabapentin Market, Regional Market Snapshot
10.2. North America Gabapentin Market
10.2.1. U.S. Gabapentin Market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gabapentin Market
10.3. Europe Gabapentin Market Snapshot
10.3.1. U.K. Gabapentin Market
10.3.2. Germany Gabapentin Market
10.3.3. France Gabapentin Market
10.3.4. Spain Gabapentin Market
10.3.5. Italy Gabapentin Market
10.3.6. Rest of Europe Gabapentin Market
10.4. Asia-Pacific Gabapentin Market Snapshot
10.4.1. China Gabapentin Market
10.4.2. India Gabapentin Market
10.4.3. Japan Gabapentin Market
10.4.4. Australia Gabapentin Market
10.4.5. South Korea Gabapentin Market
10.4.6. Rest of Asia Pacific Gabapentin Market
10.5. Latin America Gabapentin Market Snapshot
10.5.1. Brazil Gabapentin Market
10.5.2. Mexico Gabapentin Market
10.5.3. Rest of Latin America Gabapentin Market
10.6. Rest of The World Gabapentin Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Zydus Pharmaceuticals, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Glenmark Pharmaceuticals Limited
11.2.3. Sun Pharmaceutical Industries Ltd.
11.2.4. Ascend Laboratories, LLC
11.2.5. Apotex Inc.
11.2.6. Teva Pharmaceutical Industries Ltd.
11.2.7. Aurobindo Pharma.
11.2.8. Amneal Pharmaceuticals LLC.
11.2.9. Cipla USA, Inc.
11.2.10. BP Pharmaceuticals Laboratories Company
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Gabapentin Market, report scope
TABLE 2. Global Gabapentin Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Gabapentin Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Gabapentin Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
TABLE 5. Global Gabapentin Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 6. Global Gabapentin Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 7. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Gabapentin Market
TABLE 72. List of primary sources, used in the study of global Gabapentin Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Gabapentin Market, report scope
TABLE 2. Global Gabapentin Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Gabapentin Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Gabapentin Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
TABLE 5. Global Gabapentin Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 6. Global Gabapentin Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 7. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Gabapentin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Gabapentin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Gabapentin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Gabapentin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Gabapentin Market
TABLE 72. List of primary sources, used in the study of global Gabapentin Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Gabapentin Market, research methodology
FIG 2. Global Gabapentin Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Gabapentin Market, key trends 2021
FIG 5. Global Gabapentin Market, growth prospects 2022-2029
FIG 6. Global Gabapentin Market, porters 5 force model
FIG 7. Global Gabapentin Market, pest analysis
FIG 8. Global Gabapentin Market, value chain analysis
FIG 9. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Gabapentin Market, regional snapshot 2019 & 2029
FIG 15. North America Gabapentin Market 2019 & 2029 (USD Billion)
FIG 16. Europe Gabapentin Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Gabapentin Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Gabapentin Market 2019 & 2029 (USD Billion)
FIG 19. Global Gabapentin Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Gabapentin Market, research methodology
FIG 2. Global Gabapentin Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Gabapentin Market, key trends 2021
FIG 5. Global Gabapentin Market, growth prospects 2022-2029
FIG 6. Global Gabapentin Market, porters 5 force model
FIG 7. Global Gabapentin Market, pest analysis
FIG 8. Global Gabapentin Market, value chain analysis
FIG 9. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Gabapentin Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Gabapentin Market, regional snapshot 2019 & 2029
FIG 15. North America Gabapentin Market 2019 & 2029 (USD Billion)
FIG 16. Europe Gabapentin Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Gabapentin Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Gabapentin Market 2019 & 2029 (USD Billion)
FIG 19. Global Gabapentin Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
